Natural killer cells in human pregnancy

Journal of Reproductive Immunology

Volumn 97, Issue 1, 2013, Pages 14-19

  Vacca, Paola ^a   Mingari, Maria Cristina ^b,c   Moretta, Lorenzo ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Hematopoietic precursors; Natural killer cells; NK cell differentiation; Tregs

Indexed keywords

CYTOKINE;

ARTICLE; CD34 SELECTION; CELL CULTURE; CELL DIFFERENTIATION; CELL INTERACTION; DECIDUA; HUMAN; IN VITRO STUDY; MICROENVIRONMENT; NATURAL KILLER CELL; PREGNANCY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STROMA CELL; TROPHOBLAST;

ANTIGENS, CD14; ANTIGENS, CD34; CHEMOKINE CXCL10; CHEMOKINE CXCL12; FEMALE; HUMANS; INTERLEUKIN-8; KILLER CELLS, NATURAL; MYELOID PROGENITOR CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84874524883     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.10.008     Document Type: Article

References (66)

1. Apps R., et al. Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48. Hum. Reprod. 2008, 23:2535-2548.
2. Apps R., et al. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 2009, 127:26-39.
3. Barrientos G., et al. The impact of dendritic cells on angiogenic responses at the fetal-maternal interface. J. Reprod. Immunol. 2009, 83:85-94.
4. Bjorkstrom N.K., et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010, 116:3853-3864.
5. Blois S.M., et al. Dendritic cells: key to fetal tolerance?. Biol. Reprod. 2007, 77:590-598.
6. Bulmer J.N., Johnson P.M. Macrophage populations in the human placenta and amniochorion. Clin. Exp. Immunol. 1984, 57:393-403.
7. Bulmer J.N., et al. Immune cells in the placental bed. Int. J. Dev. Biol. 2010, 54:281-294.
8. Caligiuri M.A. Human natural killer cells. Blood 2008, 112:461-469.
9. Carlino C., et al. Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy. Blood 2008, 111:3108-3115.
10. Chantakru S., et al. Contributions from self-renewal and trafficking to the uterine NK cell population of early pregnancy. J. Immunol. 2002, 168:22-28.
11. Croy B.A., Xie X. In vivo models for studying homing and function of murine uterine natural killer cells. Methods Mol. Med. 2006, 122:77-92.
12. Croy B.A., et al. Identification of the primary outcomes that result from deficient spiral arterial modification in pregnant mice. Pregnancy Hypertens. 2011, 1:87-94.
13. De Maria A., et al. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFNgamma on activation. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:728-732.
14. Di Santo J.P. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 2006, 24:257-286.
15. Ebata K., et al. Immature NK cells suppress dendritic cell functions during the development of leukemia in a mouse model. J. Immunol. 2006, 176:4113-4124.
16. Fallarino F., et al. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 2003, 4:1206-1212.
17. Fauriat C., et al. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010, 115:2167-2176.
18. Ferlazzo G., et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 2004, 172:1455-1462.
19. Freud A.G., Caligiuri M.A. Human natural killer cell development. Immunol. Rev. 2006, 214:56-72.
20. Freud A.G., et al. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 2005, 22:295-304.
21. Freud A.G., et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 2006, 203:1033-1043.
22. Gregoire C., et al. The trafficking of natural killer cells. Immunol. Rev. 2007, 220:169-182.
23. Grzywacz B., et al. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood 2006, 108:3824-3833.
24. Hanna J., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 2006, 12:1065-1074.
25. Heikkinen J., et al. Phenotypic characterization of regulatory T cells in the human decidua. Clin. Exp. Immunol. 2004, 136:373-378.
26. Jones R.K., et al. Cytotoxic activity of endometrial granulated lymphocytes during the menstrual cycle in humans. Biol. Reprod. 1997, 57:1217-1222.
27. Juelke K., et al. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 2010, 116:1299-1307.
28. Kammerer U., et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am. J. Pathol. 2003, 162:887-896.
29. Karimi K., Arck P.C. Natural killer cells: keepers of pregnancy in the turnstile of the environment. Brain Behav. Immun. 2010, 24:339-347.
30. Keskin D.B., et al. TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3378-3383.
31. King A., et al. Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J. Immunol. 1996, 156:2068-2076.
32. King A., et al. Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum. Immunol. 1989, 24:195-205.
33. Koopman L.A., et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 2003, 198:1201-1212.
34. Kopcow H.D., et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15563-15568.
35. Kopcow H.D., et al. Human decidual NK cells from gravid uteri and NK cells from cycling endometrium are distinct NK cell subsets. Placenta 2010, 31:334-338.
36. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 2005, 23:225-274.
37. Laskarin G., et al. Decidual natural killer cell tuning by autologous dendritic cells. Am. J. Reprod. Immunol. 2008, 59:433-445.
38. Le Bouteiller P., Tabiasco J. Killers become builders during pregnancy. Nat. Med. 2006, 12:991-992.
39. Lin Y., et al. Characterization of natural killer cells in nonobese diabetic/severely compromised immunodeficient mice during pregnancy. Fertil. Steril. 2009, 91:2676-2686.
40. Lynch L., et al. Cells with haematopoietic stem cell phenotype in adult human endometrium: Relevance to infertility?. Hum. Reprod. 2007, 22:919-926.
41. Male V., et al. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J. Immunol. 2010, 185:3913-3918.
42. Miller J.S., McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/l3/S2. Blood 2001, 98:705-713.
43. Mingari M.C., et al. In vitro proliferation and cloning of CD3-CD16+ cells from human thymocyte precursors. J. Exp. Med. 1991, 174:21-26.
44. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002, 2:656-663.
45. Moretta A., et al. Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 1996, 14:619-648.
46. Moretta A., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001, 19:197-223.
47. Moretta L., et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 2006, 214:219-228.
48. Munn D.H., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998, 281:1191-1193.
49. Nakashima A., et al. Granulysin produced by uterine natural killer cells induces apoptosis of extravillous trophoblasts in spontaneous abortion. Am. J. Pathol. 2008, 173:653-664.
50. Peel S., et al. Experimental evidence for the bone marrow origin of granulated metrial gland cells of the mouse uterus. Cell Tissue Res. 1983, 233:647-656.
51. Ponte M., et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2a and acquire p49, an HLA-G1-specific receptor. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:5674-5679.
52. Rabinovich G.A., et al. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 2007, 25:267-296.
53. Rajagopalan S., et al. Cutting edge: induction of IFNgamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158D) in resting NK cells. J. Immunol. 2001, 167:1877-1881.
54. Saito S. Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia. Immunol. Cell Biol. 2010, 88:615-617.
55. Saito S., et al. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 2010, 63:601-610.
56. Sasaki Y., et al. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod. 2004, 10:347-353.
57. Sentman C.L., et al. Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J. Immunol. 2004, 173:6760-6766.
58. Storkus W.J., et al. NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 1987, 138:1657-1659.
59. Terness P., et al. Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am. J. Reprod. Immunol. 2007, 58:238-254.
60. Vacca P., et al. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood 2006, 108:4078-4085.
61. Vacca P., et al. Regulatory role of NKP44, NKP46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int. Immunol. 2008, 20:1395-1405.
62. Vacca P., et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11918-11923.
63. Vacca P., et al. Origin, phenotype and function of human natural killer cells in pregnancy. Trends Immunol. 2011, 32:517-523.
64. Vacca P., et al. Cd34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:2402-2407.
65. Yamaguchi T., et al. Potential selectin l ligands involved in selective recruitment of peripheral blood cd16(-) natural killer cells into human endometrium. Biol. Reprod. 2006, 74:35-40.
66. Yu J., et al. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 2010, 115:274-281.